Compare EPOW & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EPOW | NBY |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5M | 31.6M |
| IPO Year | 2019 | 2007 |
| Metric | EPOW | NBY |
|---|---|---|
| Price | $0.64 | $1.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 134.7K | ★ 608.2K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | N/A | ★ $370,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.57 | $0.43 |
| 52 Week High | $1.86 | $19.95 |
| Indicator | EPOW | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | 57.82 |
| Support Level | $0.58 | $1.01 |
| Resistance Level | $1.06 | $2.52 |
| Average True Range (ATR) | 0.06 | 0.26 |
| MACD | -0.00 | 0.11 |
| Stochastic Oscillator | 25.60 | 96.45 |
E Power Inc, through its subsidiaries, is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries. It operates a plant in Guizhou Province, China, powered by electricity from renewable sources, which contributes to the plant's low production costs and reduced environmental impact in the production of graphite anode materials. Additionally, the Group also operates a knowledge-sharing platform business. Its reportable operating segments are: Graphite anode business, which generates the maximum revenue, and Knowledge sharing and enterprise business. Substantially all of the Group's revenue is derived in the People's Republic of China (the PRC).
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.